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ABSTRACT
The blood-brain barrier (BBB) is a dynamic interface between the blood
circulation and the central nervous system (CNS). While it serves as a selective
barrier to water and solutes to prevent the blood-borne toxins from entering into the
brain tissue, it hinders the drug delivery to the CNS for the treatment of brain diseases.
Recently therapeutic antibodies and a variety of drug-loaded nanoparticles (NPs) have
been widely used to treat CNS disorders such as brain tumors, Alzheimer's disease
and Parkinson's disease. To improve brain delivery efficacy of antibodies and NPs, it
is necessary to quantify their transport parameters across the BBB and understand the
underlying transport mechanisms. In this study, we used an in vitro BBB model of a
cultured cell monolayer from an immortalized mouse cerebral microvascular
endothelial cell line, bEnd3. Permeabilities of the monolayer to antibody IgG
(MW~160kD, Stokes diameter ~10 nm), and to three neutral NPs with the
representative diameter of 22nm, 48nm and 100nm were measured using an
automated fluorometer system. The measured permeability to IgG was 22.2 (±0.56 SE,
n=12) × 10-8 cm/s and those to NPs of diameter 22nm, 48nm and 100nm were 2.58
(±0.65SE, n=8) ×10-8cm/s, 2.27 (±0.85SE, n=6) ×10-8cm/s, and 2.23 (±0.89SE, n=11)
× 10-8cm/s, respectively. By applying a previously-developed paracellular transport
model for the in vitro BBB, we predicted the permeability to IgG for a range of IgG
diffusion coefficient in the fiber-like glycocalyx at the surface of the cell monolayer,
Dfiber, from 0.001 to 0.01of its free diffusion coefficient Dfree. Our predictions suggest
that IgG is mostly likely across the in vitro BBB through a paracellular pathway. In
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addition, to explain the in vitro BBB permeability to much larger NPs without charge,
which was measured in this study and that to NPs with charge, which was measured
in Yuan et al (2010), we developed a new transcellular transport model, which
incorporates the charge at the surface glycocalyx of the bEnd3 monolayer, the
mechanical property of the cell membrane, the ion concentrations of the surrounding
salt solution, the size and charge of the NPs. Our model indicates that the negative
charge of the surface glycocalyx plays a pivotal role in transcelluar transport of NPs
of diameters ranging from 20 to100nm, regardless of charged or neutral NPs. The
electrostatic attraction between the negative charge at the surface glycocalyx of the
cell monolayer and the positive charge at NPs further increase the permeability of
positively charged NPs greatly. Our model can be used to find the optimal size and
charge of the NPs and the optimal surface charge of the BBB for an optimal drug
delivery to the brain.
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Chapter 1: Introduction
1.1 Background
Central nervous system (CNS) is one of the most sensitive systems in the
human body. Substances in the diet and from metabolism in the body, which have no
harm to the peripheral organs, are toxic to the CNS. Hence, there has to be a barrier
which can limit exchange of substances between the CNS and the blood circulation.
The interface between these two has to facilitate the transport of nutrients and restrict
the harmful molecules. The blood-brain barrier (BBB) is this interface that performs
these functions.
In 1885, Paul Ehrlich performed an experiment in which he injected a variety of
dyes into adult animals and noticed that all organs in the animals except for brain and
the spinal cord were stained (Ribatti et al., 2006). In 1898, it was the first time that the
existence of a barrier at the cerebral vascular level was proposed by Bield and Kraus
(Ribatti et al., 2006). In 1900, Lewandowsky observed that intraventricular
application of sodium ferrocyanide showed in neurological symptoms and proposed
the term “Blood Brain barrier” (Engelhardt, 2003; Ribatti et al., 2006). Spatz (1922)
was the first to argue that the capillary endothelium was the essential structure
(Suckling et al., 1986).
With the development of electron microscopy, Reese and Kamovsky (1967)
were the first to show the ultra structural features of the cerebral capillaries (TS. and
MJ., 1967). They believed that the endothelial cells and their tight junctions (TJs)
between adjacent cells constructed the blood brain barrier (Ribatti et al., 2006).
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Brightman (Brightman, 1968) substantiated the above observations of Reese and
Kamovsky with his own observations. He carried out the experiment by injecting
either ferritin or HRP intraventricularly and observed that ferritin/HRP passed
between the ependymal cells into the brain interstitial fluid and reached the basement
membrane through astrocytic end feet gap junctions. The tracers were stopped at the
basement membrane by the endothelial cells (Ribatti et al., 2006). The observations
by Reese, Kamovsky and Brightman collectively demonstrated the anatomical
structures of the BBB.

Figure 1.1 The cross-sectional view of the blood-brain barrier (Li et al.,
2010b).

Wislocki
(1891) used Trypan blue as the dye which stained most of the tissues
.
except the brain. In 1905, Behensen injected Trypan blue into mice and observed
accumulation in brain. Broadwell and Brightman (1976) did the same kind of
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experiment with the tracer HRP (Ribatti et al., 2006). Other researchers who worked
with Trypan blue were Stern and Rapoport in 1927. They injected dye into rabbits,
cats, rats and mice and observed that the dye did not penetrate into brain (Ribatti et al.,
2006).
BBB plays a major role in regulation of material exchange between the CNS and
the circulating blood due to its unique structure. The brain microvessels are observed
to be ~ 50 to 100 times tighter than those in the peripheral tissue (Abbott, 2002). The
capillaries of endothelium in the brain have its unique structure like narrowed tight
junctions, absence of fenestrations, continuous basement membrane and low pinocytic
activity. These special features make them different from the peripheral capillaries
(Gaillard et al., 2006).
Figure 1.1 shows the anatomical structure of the BBB. The inner wall of the
BBB is formed by endothelial cells. At the luminal surface of endothelial cells, there
is a fluffy fiber-like glycocalyx layer (Ueno et al., 2004), which consists of
chondroitin sulfate proteoglycan, heparin sulfate proteoglycan and hyaluronic acid
(Henry and Duling, 1999). Due to these compositions, the surface glycocalyx carries
negative charge (Squire et al., 2001; Tarbell and Pahakis, 2006; Weinbaum et al.,
2003). The unique structure and location of the glycocalyx determine its role in
maintaining the low BBB permeability. In addition to the surface glycocalyx, tight
junctions between the adjacent endothelial cells behave like the gatekeeper making
the blood-brain barrier block the movement of most of molecules except those that
can cross the cell membranes by means of lipid solubility (such as oxygen, carbon
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dioxide, ethanol, and steroid hormones) and those that are allowed in by specific
transport systems (such as sugars and some amino acids). Besides the tight junctions,
the basement membrane wraps the capillary on the abluminal side. The basement
membrane is mainly composed of collagen type IV, heparin sulfate proteoglycans,
laminin, fibronectin, and other extracellular matrix (ECM) proteins (Leblond and
Inoue, 1989; Miosge, 2001), which form a uniform matrix-layer providing additional
resistance to molecule movement across the BBB. Furthermore, the basement
membrane has been completely wrapped by astrocytes (Farkas and Luiten, 2001;
Hawkins and Davis, 2005) at the tissue side. Astrocytes are characteristic star-shaped
glial cells in the brain and spinal cord. The astrocyte end feet clasp the basement
membrane and cover ~98% of the brain microvasculature surface (Cohen et al., 1995;
Pardridge, 1999). They thus play an important role in controlling nutrient supply to
the nervous tissue, maintenance of extracellular ion balance, and the repair and
scarring process of the brain and spinal cord following traumatic injuries.
Many CNS diseases are related to the breakdown of the structural integrity of
BBB and disruption to its normal function. Multiple sclerosis, brain edema,
encephalitis, head injury, meningitis, brain cancer and ischemic stroke are a few
diseases, which can alter the permeability of BBB (Baldwin et al., 1996; Beaumont et
al., 2000; Cernak et al., 2004; Dietrich et al., 1994; Fukuda et al., 1995). BBB plays a
very important role in drug delivery to the brain. Blood flow becomes a limiting
factor for the drugs that can pass the BBB, whereas for the other drugs, BBB
permeability is restrictive (Boer et al., 2003). Another factor that influences the
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passage of drug through BBB is protein binding.

This controls the free fraction of

drugs/compounds and their distribution in blood, which in turn influences the amount
of drugs/compounds that pass through the BBB. Even though it has been understood
that numerous biochemicals induced by CNS diseases affect the tight junction and
eventually disrupt the structural components of BBB to increase its permeability, it is
not clear how to control the BBB permeability to efficiently deliver the therapeutic
agents to the brain.

1.2 Transport pathways across the blood brain barrier
Various transport processes (including influx and efflux transporters) regulate
BBB homeostasis by operating at BBB to supply and eliminate substances to and
from the endothelial compartment, and subsequently from the brain (Boer et al.,
2003).

Figure 1.2 Transport pathways in the blood-brain barrier (Olivier, 2005).
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There are six routes of transport across the blood brain barrier, which are
shown in Figure 1.2 (A to F). Tight junctions permit the diffusion of only very small
amounts of water-soluble compounds – paracellular pathway (A). Large surface area
of the lipid membranes of the endothelium offers an effective diffusive route for
lipid-soluble molecules - transcellular lipophillic pathway (B). The large neutral
amino acid transporters (C), like the glucose transporter, are present on both the
luminal and abluminal membranes of endothelial cells and are bidirectional, although
they are most important for the influx to the brain. Protein transport systems exist for
hexoses (glucose, mannose, and galactose), monocarboxylic acids (acetic, lactic, and
pyruvic acids), large neutral amino acids (tyrosine, phenylalanine, and isoleucine),
acidic amino acids (glutamate and aspartate), basic amino acids (arginine and lysine),
nucleic acid precursors (adenine, adenosine, and guanine), choline, and thyroid
hormones (via transthyretin). Some proteins, such as insulin and transferrin are
transported by receptor mediated endocytosis (D). Endocytosis in general is a process
whereby a cell absorbs materials (molecules such as proteins) from the outside by
engulfing them with its cell membrane (Boer et al., 2003). There are two different
transcytosis systems, the receptor-mediated transcytosis (D) and cell surface
charge-mediated

transcytosis

(E).

Potassium

efflux

is

achieved

with

an

energy-dependent process that exchanges sodium for potassium at the abluminal
membrane,

with

adenosine

triphosphate

(ATP)

as

the

energy

source

(Na+/K+-adenosine triphosphatase). P-glycoprotein (P-gp), which is localized at the
luminal membrane of endothelial, pumps amphipathic organic cations or neutral

11

compounds out of the CNS into the blood, while multidrug resistance-associated
protein (MRP) and organic anion transporter (OAT) pump anions out of the CNS as
efflux proteins (F).

1.3 Previous studies in transport across the blood brain barrier
Blood brain barrier is such a complicated barrier that even after numerous
scientists have tried to decode its complexity, very little has been discovered so far.
Below is a brief summary for experiment studies and mathematical models on the
transport of water and solutes across the BBB.

Experimental studies on permeability of BBB
In vivo
The in vivo frog and rat models have been developed for investigating transport
across the BBB. The pial microvessel has been commonly used as a model system for
studying blood-brain barrier (BBB) properties instead of cortical cerebral
microvessels because the pial microvessels are on the surface of brain parenchyma
which are easier to locate (Allt and Lawrenson, 1997a). Easton and Fraser (1994,
1997) was the first to quantify the water and solute permeability using single pial
microvessel occlusion technique on frogs and rats by exposing the rat brain. Gaber et
al. (2004) measured dye clearance or leakage rate out of the rat pial microvessels by
injecting a fluorescence dye through the left femoral vein. Their experiments did not
measure the concentration difference across the microvessel wall and thus the
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permeability of the microvessel could not be determined. Yuan (Yuan et al., 2009)
developed a non-invasive method and quantified the apparent permeability (P) of
post-capillary venules on rat pia mater to various sized solutes. Their method
overcomes the above mentioned disadvantages by determining the concentration
difference across the microvessel wall but not exposing the rat brain. However, all
these in vivo experiments are extremely time consuming, require high skilled
researchers and high cost as well. Hence, in vitro BBB models were developed for
low cost, high-throughput screening, and easiness to assess compounds as well as to
investigate the transport mechanism at molecular levels.

In vitro
To search for the closest structure to BBB phenotype, many in vitro models have
been derived and investigated (Nicolazzo et al, 2006). The cultured cell monolayer
from the primary cells of brain capillary endothelium can resemble the BBB structure,
but they easily loose the morphology phenotype after several passages besides the
disadvantage of potential contaminations.
The co-culture models were the ideal models to mimic the in vivo BBB by
co-culturing brain microvascular endothelial cells with astrocytes and/or pericytes. Li
(Li et al, 2010) developed a co-culture in vitro BBB system by co-culturing bEnd3 (an
immortal mouse brain microvascular endothelial cell line) with primary astrocytes
from mouse brains. Their study concluded that the endothelial monoculture and the
co-culture models are fairly good models for studying the transport of relatively large
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solutes across the BBB. Yuan (Yuan et al., 2010) measured the permeability of this in
vitro BBB to charged solutes and nanopartilces. They found that at the surface of
bEnd3 monolayer there is a glycocalyx layer with comparable thickness and charge
density as observed in real microvessels. They also found that the permeability of the
bEnd3 monolayer to positively charged nanoparticles (NPs) of diameter 66-88 nm is
the same as that to much smaller solute, Dextran 4k (Stokes diameter ~2.8 nm).
Considering the width of the paracellular pathway between endothelial cells is only
~18 nm, the 66-88 nm diameter NPs are most likely across the bEnd3 monolayer
through a transcellular or transcytosis pathway. The transcytosis induced by
electrostatic attraction have been studied with cationized solutes, such as charged gold
coated NPs and latex NPs (Gil et al., 2009; Harush-Frenkel et al., 2008; Smith and
Borchardt, 1989; Yacobi et al., 2010; Yuan et al., 2010). However, the underlying
transport mechanism remains unknown.

Mathematical modeling
Paracellular model
To predict the permeability of the blood brain barrier to water and small
hydrophilic solutes based on ultra structural studies of the paracellular pathway of the
BBB, Li et al. (Li et al., 2010b) developed a mathematical model for the transport of
water and solutes through the paracellular pathway of the BBB. Their model was
extended from the previous three dimensional model for the transport across a
peripheral microvessel wall in which there is no surrounding basement membrane and
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astrocyte foot processes around the endothelial cells (Brightman, 1968; Fu et al.,
1994).

Figure 1.3 Model geometry for the paracellular pathway of the BBB (not in scale). In
this study, the surface glycocalyx layer and the endothelial cells are defined as the
endothelium only while the BBB is defined to include the endothelium, the basement
membrane and the astrocytes (Li et al., 2010b).

The model geometry is shown in Figure 1.3. This model gives a good prediction
for the paracellular water and solute transport across the blood brain barrier, which
indicates that the basement membrane and astrocyte foot processes of the BBB play
an important role in maintaining the low permeability of the BBB and thus provide a
significant protection to the CNS under both physiological and pathological
conditions.

Transcellular model
Recently, Fleck and Netz (Fleck and Netz, 2004) developed a mathematical
model to describe the wrapping process of charged membrane and oppositely charged
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particles (Figure 1.4). They investigated the effects of ion concentrations of the
solution and mechanical properties of cell membrane on the wrapping process. Their
wrapping model provides a base to develop a transcellular model for the large NP
transport across an in vitro BBB.

Figure 1.4 Schematic illustration of a model prediction for the wrapping of a
charged particle of radius R by an infinitely large membrane carrying opposite
charge. a) The cell membrane deformation when wrapping the same size particle
with different charge (8.54, 8.38 and 7.82 indicate the charge number). b) The
geometry of the deformation is simplified as fixed flat cell membrane in
surrounding area and osculating circle in contact surface. h indicates the
displacement of the sphere (Fleck and Netz, 2004).

1.4 Significance and objectives of the study
Compared with peripheral organs, the permeability of microvessels to water and
in the brain is much lower (Tuma, 2003). In addition, the brain endothelial cells have
lowest frequency of caveolae (<100/ m3) (Dehouck et al, 1994), so there is a limit for
caveolae-mediated transcytosis across the BBB. These unique features of the BBB
16

thus hinder the drug delivery to the brain. Over the last two decades, researchers have
developed many means to improve the delivery. Recently, immunoglobulins (IgGs)
and nanoparticles (NPs) have been widely used as drug carriers for drug delivery
(Brigger et al., 2002; DeAngelis, 2001; Feng et al., 2004; Kornblith and Walker, 1988)
because 1) they are nontoxic, biodegradable and biocompatible; 2) they maintain
physical stability in the blood and have relatively long blood circulation time; and/or
3) the ability to recognize targeting sites (Olivier, 2005)
IgGs, also known as antibodies, are substances made by the body's immune
system in response to outside antigens such as bacteria, viruses, fungus, animal dander,
or cancer cells. Antibodies themselves can be therapeutic. They can also be
conjugated with the radioactive isotopes in radioimmunotherapy. NPs, made of
liposomes, polymers and metals, usually have diameters from 10nm to1000nm. It has
been found that NPs under 200nm in diameter display a decreased rate of plasma
clearance and thus an extended circulation times as compared to those with a larger
diameter (Singh, 2010).
In general a pharmaceutical agent will distribute evenly within the whole body if
injected through systemic administration. An ideal drug distribution requires a higher
local concentration at the disease organs/tissues, and lower concentration in other
non-target organs/tissues to prevent the possible side-effects. The advantage of using
antibodies is that they can specifically bind to the antigens at the diseased tissues and
reduce the toxic effect on healthy tissues. For NPs, not only can we alter the surface
properties to improve bioavailability and biocompatibility but also conjugate them
with antibodies or peptides for specific targeting. Furthermore, we can load small
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molecular weight agents on to NPs to elongate their circulation time. For example,
small molecules can be encapsulated in nanospheres regardless of their water
solubility. They can be either hydrophilic (e.g., ampicillin, doxorubicin) or
hydrophobic (e.g., saquinavir, paclitaxel). An ideal therapeutic-delivery NP system
for treating brain diseases would be coated with targeting agents for selectivity, with a
positive charge for an increased cell uptake, and with permeability-enhancing agent
for penetrating the BBB (Juillerat-Jeanneret, 2008).

To improve the antibody and NP delivery efficacy to the brain, we need to
quantify their ability to pass the BBB and understand how they cross the BBB.
Therefore the first objective of this study was to measure the permeability of an in
vitro BBB (bEnd3 monolayer) to IgG and NPs. The second objective of this study
was to investigate their transport pathways and understand the underlying transport
mechanism. To accomplish this, we used a previously developed paracellular
transport model and developed a new transcellular transport model to predict the
permeability of the in vitro BBB to IgG and to various sized NPs with and without
charges. By comparing the predicted permeability with measured permeability data,
we can identify the transport mechanism for IgG and NPs.
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Chapter 2: Permeability of an in vitro BBB to IgG and
Nanoparticles
The cultured monolayer of bEnd3, an immortalized mouse cerebral
microvascular endothelial cell line, is a popular in vitro BBB model due to its easy
growth and maintenance of many BBB characteristics over repeated passages. The
surface glycocalyx layer (SGL) at the bEnd3 monolayer also has a comparable
thickness and charge density to those of the intact BBB endothelium (Yuan,
2010a;Yuan, 2010b) Therefore we used the bEnd3 monolayer as the in vitro BBB to
measure its permeability to IgG and NPs.

2.1 Materials and Methods
2.1.1 Materials
Rat IgG (Dylight 549, MW ~160kD, ChromPure) was purchased from Jackson
Immunoresearch. Fluorescently-labeled polymer nanospheres with diameters 22nm,
48nm and 100nm were purchased from Fisher. Fibronectin and bovine serum albumin
(BSA) were purchased from Sigma, St. Louis, MO. Fetal bovine serum (FBS) was
from Hyclone, Logan, UT. Immortalized mouse cerebral endothelial cells (bEnd3
cells) were from American Type Culture Collection, Manassas, VA. Transwell filters
(0.4 m pore size, 12mm, 12 inserts in a plate) were purchased from Corning
Incorporated, Corning, NY.

19

2.1.2 Cell Culture
The bEnd3 cells were grown in DMEM with 4.5 g/L glucose, 10% FBS, 3.7 g/L
sodium bicarbonate. Cells were maintained in a humidified cell culture incubator at
37℃ and with 5% CO2/95% room air. Cells used in all experiments were seeded at
8.0 x 104 cells/cm2 on Transwell permeable filters. The filters were first incubated at
37 ℃ with 200 L of 30 g/mL fibronectin for 1.5 h before plating cells. The cells
seeded onto Transwell filters reached confluence within approximately three days.
The cells were cultured in DMEM cell culture media with 10% FBS for the first 48
hours and then cultured in DMEM cell culture media with 2.5% FBS for 24 hours.
The permeability experiments were performed on the monolayer 72 hours after cell
seeding, allowing sufficient time for the cells to develop the junctions between cells.

2.2 In Vitro Solute Permeability P Measurement
2.2.1 Measurement of solute permeability P
The solute or NP permeability P of the cell monolayer was measured using a
previously developed bubble tracker system and automated fluorometer system as
shown in (Figure.2.1) (Cancel et al., 2007; Cancel and Tarbell, 2010; Li et al., 2010a).
On the day of experiment, Transwell insert filters with the cell monolayer were
washed twice with the experimental solution containing 1% BSA and 1% PBS in
DMEM medium free of phenol red, and then the upper chamber was filled with 1 mL
0.2μM fluorescently-labeled IgG or 0.025nM polystyrene NPs in the experiment solution,
while the bottom chamber was also filled with the experimental solution (Figure. 2.2).

20

Figure 2.1 Schematic of the experimental system used to measure the
permeability of cell monolayers to water and fluorescently-labeled solutes.

The bottom chamber was connected to a laser excitation source and an emission
detector via optical fibers arranged in a 45°configuration. The fluorescent tag of the
test solute or NP in the upper chamber was excited by the excitation light produced by
a 10-mW Crystal laser and the emission was counted by a photon counting detector.
The excitation wavelength was set to 532nm and emission wavelength was 598 nm.
The data was recorded by the FluoroMeasure acquisition software (C&L Instruments,
Hummelstown, PA). The bottom chamber was also connected to a water reservoir by
a Tygon and borosilicate glass tube as shown in Figure.2.1. A hydrostatic pressure
difference could be created across the filters by adjusting the height of the reservoir
with respect to the height of the fluid covering the cell monolayer. Water flux across
the cell layer was measured by tracking the position of a bubble pre-inserted into the
glass tube. Both the upper chamber and bottom chamber were continuously supplied
with 5% CO2/95% air to maintain the pH of the medium at 7.4. The temperature of
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the whole permeability measurement system was maintained at 37 ℃ . Each
experiment lasted 4 h: the first hour for equilibration without hydrostatic pressure, Δp
= 0; the second hour for data collection under convective condition, applying the
10cm hydrostatic pressure, Δp = 10 cmH2O; and the final two hour of data collection
under diffusive conditions without hydrostatic pressure, Δp = 0.

2.2.2 Calculation of Permeability P
Filter, seated in chamber

Upper Chamber,
Concentration Cu
Porous membrane,
Surface area A
Bottom chamber,
Concentration Cb,
Volume Vb

Figure 2.2 Schematic of the chambers with the transwell filter covered with cultured cell
monolayer.

FluoroMeasure acquisition software was used to measure the fluorescence
intensity in the bottom chamber, which was recorded every 10 seconds for the
duration of the experiment. The intensity was converted to concentration by a
calibration curve, and the solute permeability P of the monolayer was calculated by
P

Vb C b / t
A
Cu

where P is the permeability, Cb tis the increase rate of solute or NP concentration
in the bottom chamber, calculated through the slope of the intensity vs. time curve
shown in Figure 2.3, which was directly measured in the experiment. Vb is the fluid
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volume in the bottom chamber (Figures 2.2), Cu is the solute or NP concentration in
the upper chamber, which was assumed to be constant due to low permeability of the
cell monolayer. A is the surface area of the porous membrane.

b)

Time (hour)

Figure 2.3 Fluorescence intensity vs. time curves measured by the fluorometer
system. a) the curves measured for IgG, b) the curves measured for NPs.
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2.3 Results for the Permeability of bEnd3 Monolayer to IgG and
Neutral NPs
Experimental results for the permeability P of bEnd3 monolayer to IgG and NPs
are summarized in Table 1. Here P is diffusive permeability obtained under zero
hydrostatic pressure difference (Δp=0). The mean permeability of bEnd3 monolayer
to IgG PIgG is 22.2 (±0.56SE, n=12) x 10-8 cm/s. The permeability of bEnd3
monolayer to NPs of diameter 22nm, 48nm and 100nm are P22nm=2.58 (±0.65SE,
n=8)×10-8cm/s, P48nm=2.27 (±0.85SE, n=6)×10-8cm/s and P100nm=2.23(±0.89SE,
n=11)×10-8cm/s, respectively.

Table 1 Measured permeability (P) of bEnd3 monolayer to IgG and neutral NPs
under Δp=0.
Solutes

Diameter

P×10-8 (cm/s)

IgG

~11nm

22.2 (±0.56SE, n=12)

Neutral NPs

22nm

2.58 (±0.65SE, n=8)

48nm

2.27 (±0.85SE, n=6)

100nm

2.23(±0.89SE, n=11)
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Discussion
From Table 1, we found that the permeability of bEnd3 monolayer to IgG with
diameter ~11nm is about 10 times that of NPs with 2 to 5-fold of IgG diameter.
Interestingly, the permeability to NPs with diameter of 22nm, 48nm and 100nm are
similar to each other, independent of their sizes. Also from Figure 2.3, we observed
that for IgG, when applying Δp=10cm H2O, the slope of the intensity vs. time curve
increases, indicating an increased permeability (Figure 2.3a). If IgG crosses the in
vitro BBB through the paracellular pathway, the same route as for the water, applying
hydrostatic pressure difference would induce a convective transport of IgG and thus
increase its apparent permeability. However, when applying the same hydrostatic
pressure difference, no significant change was observed in the slope of the intensity
vs. time curve for the NPs (Figure 2.3b), implying that the much larger NPs may cross
the in vitro BBB through the transcellular pathway, which is not affected by the water
movement.

Therefore, in Chapter 3, we used a previously-developed paracellular

transport model and developed a new transcellular transport model to predict the
permeability of the in vitro BBB to IgG and to various sized NPs with and without
charges. By comparing the predicted permeability with measured permeability data,
we can identify the transport mechanism for IgG and NPs.
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Chapter 3. Transport models for IgG and Nanoparticles
across the in vitro BBB
As analyzed in Chapter 2, we speculated that the IgG crosses the in vitro BBB
through a paracellular pathway while the much larger NPs through a transcellular
pathway. In this chapter we applied an existing paracellular model for the in vitro
BBB to confirm the paracellular transport of IgG. We also developed a new
transcellular model for the in vitro BBB to study the NP transport.

3.1 Paracellular transport model
3.1.1 Model Geometry
The paracellular pathway is a transport pathway for water and hydrophilic solutes
across the BBB (Figure 1.2). Li et al. (2010) and Yuan et al. (2010a) had developed a
paracellular transport model for the in vitro BBB.

Figure 3.1.1 The schematic diagram of bEnd3 monolayer. There is a cleft (width 2B)
with a tight junction (opening width 2Bs and thickness Ljun) in between two adjacent
endothelial cells (E). The thickness of the endothelial cell is L and the distance between
the luminal side of the endothelial cell and the tight junction is L1. At the luminal side of
the endothelium, there is a surface glycocalyx layer with a thickness Lf. (Yuan et al.,
2010a)
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In this model, there is a glycocalyx layer at the endothelial surface. This
glycocalyx layer carries negative charge. There is a cleft (paracellular pathway) with
tight junctions between adjacent endothelial cells forming the in vitro BBB (bEnd3
monolayer). Figure 3.1.1 shows the geometry of their model. The anatomical
parameters of bEnd3 monolayer are listed in Table 2 (Yuan et al., 2010a). The width
of the inter-endothelial cleft is 18nm and the open region of the tight junction has a
width of 11-15nm, which allows the passage of IgG with ~11 nm diameter but
excludes the larger sized NPs.
Table 2

Anatomical parameters of bEnd3 monolayer (Yuan et al., 2010a)

Fiber radius of surface glycocalyx layer3
Gap spacing between fibers of glycocalyx
Thickness of endothelial cells
Distance between the junction strand and the front of
the cleft
Width of inter-endothelial cleft
Width of the small slit of the junction strand
Thickness of tight junction strand
Width of endothelial cells
Total cleft length per unit endothelial monolayer
surface area

rf
D
L
L1
2B
2Bs
Ljun
2D
Ljt

6 nm
8 nm
700 nm
350
18
11~15
11
20

nm
nm
nm
nm
μm

603 cm/cm2

3.1.2 Model Predication
We knew all the anatomical parameters for the in vitro BBB from the literature
(Table 2) and can calculate the transport parameters of IgG in the cleft. However,
there is no theory allowing us to calculate the diffusion coefficient of IgG, Dfiber, in
the glycocalyx layer, we thus assumed a range of Dfiber/Dfree from 0.0001 to 0.01.
Figure 3.1.2 shows our model prediction.
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Permeability (x10-7 cm/s)

3.5

Model prediction

3.0
Mearused IgG
Permeability

2.5
2.0
1.5
1.0
0.5
0.0
0

0.001 0.002 0.003 0.004 0.005 0.006 0.007 0.008 0.009 0.01
Dfiber/Dfree

Figure 3.1.2 Comparison of the model prediction and the measurement for the
permeability of bEnd3 monolayer to IgG. The blue line is the model prediction and
the orange symbol measured data (mean ±SD).

The blue line in Figure 3.1.2 shows the model prediction of the permeability of
bEnd3 monolayer to IgG as a function of Dfiber/Dfree, while the orange triangle
represents the experimental result. Comparing the model predictions with measured
data, we can see that for the best fit to the measured P to IgG, the Dfiber/Dfree, would be
0.0076 ranging from 0.005 to 0.01 when considering the deviation in the measured
data. This value of Dfiber/Dfree for IgG seems reasonable. Our results thus suggest
that IgG is most likely across the BBB through a paracellular pathway.
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3.2 Transcellular Transport model
3.2.1 Comparison of Permeability of bEnd3 Monolayer to Charged and

Permeability (x10-8 cm/s)

Neutral NPs
1000

Charged NPs (Yuan et al 2010)
Neutral NPs

100

10

1
0

20

40

60

80

100

120

Diameter (nm)
Figure. 3.2.1 Comparison of bEnd3 cell permeability to charged NPs (red squares) and
neutral NPs (blue diamonds). The permeability was plotted as mean+SE. Permeability to
charged NPs are from Yuan et al. (Yuan et al., 2010).

Figure 3.2.1 compares the permeability of bEnd3 monolayer to NPs of various
sizes with and without charges. The charged NP with diameter of 65.3± 4.3, 77.3± 4.1,
and 88.0± 3.8 nm has the zeta potential 6 mV, 11.8 mV and 14mV, respectively (Gil
et al., 2009). The neutral NP has the diameter of 22.0, 48.0 and 100.0nm. We can see
from Figure 3.2.1 that although the charged and neutral NPs have the similar size, the
permeability of the bEnd3 monolayer to the charged NPs is roughly 100 folds that to
the neutral NPs. Interestingly, we can also observe that to both neutral and charged
NPs, the permeability of the bEnd3 monolayer is similar regardless of sizes for the
diameter in the range of 20-100 nm. The observations from the measured permeability
data and that the size of these NPs is much larger than the width of the paracellular
pathway lead us to postulate that for the NPs in this size range, the pathway across the
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BBB is most likely to be a transcellular one. It is also realized that the charge at the
NPs and that at the surface glycocalyx layer of the bEnd3 monolayer should play a
crucial role in the transcellular transport. To investigate this transcellular mechanism,
we thus developed a trancellular transport model for the bEnd3 monolayer.

3.2.2 Model Geometry
In this trancellular transport model, we considered how a cell membrane with
negative charge wraps around a neutral or positively charged spherical particle. The
cell membrane was described as an elastic surface (Helfrich and Servuss, 1984). The
charge at the cell membrane and that at the NP were assumed to be uniform.

Endocytosis ⬇
h

Exocytosis ⬇

Figure 3.2.2 The schematic diagram of bEnd3 cell interacting with a charged (or
neutral) spherical NP in an ionic solution. The NP has the radius R, charge number Z. h
indicates the penetrating distance of the NP into the cell. The cell membrane has the
charge density σ. The thickness of the endothelial cell is Lec (not in scale).
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Figure 3.2.2 shows the model geometry. The charged (or neutral) NP has the
radius R and the charge number Z. The cell membrane is described as a
two-dimensional elastic surface and has charge density per area of cell membrane
and the thickness of the cell Lec. The cell membrane was stretched by internalization
of the NP due to the electrostatic force as well as the surface tension. Since the
diameter of the cell is about 20 m, and the NP is ranging from 22nm to 100nm
diameter, the cell membrane can be assumed to be infinitely large compared to the NP.
Therefore the unwrapped region of the cell membrane can be assumed to be flat.

Debye-Huckel Length and Bjerrum Length
Before describing the interaction of a charged (or neutral) NP with the charged
cell membrane in a colloidal system, we first induced Debye-Huckel length, which
characterizes the distance within which the electrostatic interaction is significant. For
a charged object in a colloidal solution, the electric double layer is formed around the
object due to the movement of free ions in the solution. The electric double layer
refers to two parallel layers of charge surrounding the object (Figure 3.2.3). The first
layer, called Stern Layer, the surface charge comprises ions fixed directly onto the
object due to opposite charge electrostatic interactions. The second layer, called
diffusion layer, is composed of ions attracted to the surface charge, electrically
screening the first layer. This second layer is loosely fixed compared with the first
layer, because it is made of free ions which move in the fluid under the influence of electric
attraction and thermal motion rather than being firmly fixed. It is thus called the diffusion layer.
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Figure 3.2.3 Schematic of the electrostatic interaction for a negatively charged
sphere in a salt solution. The Stern plane, also called the Stern layer, is the layer
in which the opposite charges/ions are fixed on the sphere. The Slipping plane,
also called diffusion layer, is the layer in which the ions can move around.
(www.substech.com)

Figure 3.2.3 also shows the length from a sphere

κ, which is determined as

Debye-Huckle length, also called Debye length/radius, is the distance within which
the electrostatic interaction between two charged objects is significant. At this length,
the electrical potential equals the zeta potential, which is the apparent potential for the
charged object in a colloidal system, k is given by

, where C is the salt

concentration of the solution. lB is the Bjerrum length, the distance at which the
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electrostatic interaction between two elementary charges is comparable to the thermal
energy,

εε

, where e is the elementary charge, ε is the relative

dielectric constant of the medium and ε is the vacuum permittivity. KB is the
Boltzmann constant. Temp is the absolute temperature. Table 3 shows the values for
these parameters.

3.2.3 Model Formulation
Interaction between oppositely charged sphere and the cell membrane
For the electrostatic sphere-cell membrane attractive interaction due to opposite
charge, we have the electrostatic potential (Netz and Joanny, 1999)
ν

κ

κ

where r is the distance from the centre of the sphere to the a point on the cell
membrane, R is the radius of the sphere. For the oppositely charged cell membrane to
cell membrane electrostatic interaction, we have the electrostatic potential
ν

κ

Helfich theory can be used to study the mechanical properties of living cell
membranes (Helfrich and Ou-Yang,1987). The elastic energy per unit area g is
γ
where c1, c2 are the principal curvatures of the membrane, Kc is the bending rigidity of
the cell membrane, γ is the surface tension of the cell membrane. The total energy
Emech of the elastic deformation is

, integration over the deformation

area, where dA is the surface element.
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For the interaction of oppositely charged NP and cell membrane in a salt solution,
a total energy can be expressed as
(1)
ρ

ρ

σ

σ

ρ

ρ
ρ

ρ

ρ ,

ρ

ρ
ρ′

γ

(3)

ρ

ρ

ρ

(2)

′

ρ

′
ρ

ρ
′

(4)

ρ

Here Emech is the energy due to the mechanical deformation of the cell membrane. Eattr
is the energy due to the attraction between oppositely charged sphere and the cell
membrane. Erep is the energy due to the repulsion between one part of the cell
membrane and another part of the cell membrane.
membrane,

=( 1, 2) is the internal coordinates of the membrane, g( ) is the

determinant of the first fundamental form. γ
γ

γ

X( ) is the position on the

γ

is the effective surface tension

where γ is the mechanical surface tension of the cell membrane due

to its bending rigidity and γ

is the electrostatic surface tension of the cell

membrane due to the charge of the cell membrane and the surrounding salt solution
γ

π σ κ.

Here σ is the charge density of the cell membrane, 1/

Debye-Huckle length.

is the

, in which C is the ion concentration of the

surrounding solution (Fleck and Netz, 2004).
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Figure 3.2.4 The schematic shows the deformation of the cell
membrane. The strain (relative deformation of the cell membrane)
can be expressed in terms of h and R. The blue dash line indicates
the negative charge on cell membrane, the black lines indicate the
cell membrane. h indicates the penetrating distance of NP into the
cell.

In the spherical coordinate, we expanded the above equations and rescaled them
into dimensionless forms with the characteristic parameters (Fleck and Netz, 2004):
σ

，

, σ

σ

, γ

depth for the wrapping (Fig.3.2.4),
γ
σ
σ

σ

. When

,

. h is the penetrating
, kR>>1, we have
(5)

,

(6)
σ

σ

The total energy is
The total force

γ

.

(7)

(8)

acting on the cell membrane is the derivative of energy with

respect to h,
(9)
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The contact area of the sphere to the cell membrane is
(10)
Then, the stress is expressed as α
The strain
ε

(11)

can also be expressed in terms of

. The strain are defined as

, where Lt and L0 are the length at time t and length at the beginning,

respectively. As shown in the Fig.3.2.4,
L0=2R,

,

then
ε

(12)

Table 3 Parameters in the transcellular model
Symbol Name
Vacuum permittivity
0

Value
8.8542x10-12

Relative permittivity

71.12

Electron charge
Boltzmann constant
Absolute temperature
SGL volume charge
v
density +
Bending Rigidity*
Kc
Sphere radius
R
Surface tension*
Salt concentration+
C
* Data from Denson et al 2008.
+
Data from Yuan et al 2010.
++ Data from Tan et al 2008.
e
KB
T
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Unit
c /N m2
2

1.602x10-19
1.38×10−23
310

C
J/K
K

20~30

mEq/L

20~100KBT
22~100
1~10x10-2
140

J
nm
pN/nm
mM

3.2.4 Viscoelastic Behavior of the Cell Membrane
The cell membrane has been described as a viscoelastic material by many studies
(Jamali et al., 2010; Sato et al., 1990) when dealing with the deformation problems
such as cell adhesion and aspirating cell membrane by micropipette. The mechanical
properties of the cell membrane can be determined by experiment measurements. In
our transcellular transport model, we used a standard linear solid model (Figure 3.2.5)
to describe the viscoelasitc behavior of the cell membrane.

Figure 3.2.5 A standard linear solid model with one dashpot and
one spring in parallel with another spring. This model is widely
used to describe the viscoelastic behavior of the cell membrane.

The constitutive equation for this viscoelastic material is,

(k1  k2 )

d
k d k1k2
  2


dt
 dt


(13)

here k1, k2 is the elastic properties of the cell membrane, and the
the cell membrane. The experimental measurements give

is the viscosity of

＝8300 ± 4000PaS, k1=

200~700Pa and k2=76~112Pa. The constitutive equation can be written in a
dimensionless form as in below,

d d
1
d
k  k2

(
)
）  where t  T , τ  μ 1
dT dT k1  k 2
k1
k1k 2
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(14)

By substituting equation (8), (9), (10) and (11) into (14), we get a non-linear first
order ordinary differential equation
~
dh

dT

here 

~
~
~
~
4Z~ 2 ~ 1
~ 2
3~ 2
5~ 2
  ((2 + ~eff 
)h 
h 1.5 
h 0.5 
h 0.5  
2
2
2
1  R
2 (R )
8 2 (R )
32 2 (R )
~
~
~ 2.5
~
~
h

4Z~ 2 ~ 2
3~ 2
3~ 2
5~ 2
~

h 1.5 
h 0.5 )
2
2
~ ~ 2   ( (2 +  eff  1  R )h  2 2 (R )2 h
16 2 (R )
64 2 (R )
2h  h

 1

k2 ,
K K T
  C B2
k1
k2 R

(15)

. The above equation can be solved by Runge-Kutta

method.

Initial Condition
For the standard linear solid model, the springs on both arms response
immediately when the force is applied and the dashpot remains still. The deformations
of the springs on both arms are the same and obey the Hook’s law. Therefore, at the
beginning when t=0, there is a initial penetrating distance h0 due to the applied stress.
The following equations can be used to solve for the initial h0 at t = 0, which is the
initial condition used for Eq. 15.
~
dE 1
 ~
 (k1  k2 )ε0
dh 2πRh0

~

~

 0  arccos(1  h0 )  sin(arccos(1  h0 ))

3.2.5 Permeability P determined by the Transcellullar Model
The permeability P of the BBB to a NP indicates how fast a NP can cross the
BBB. For an in vitro BBB of the bEnd3 monolayer, a NP has to enter the cell
membrane into the cell (endocytosis), diffuse in intracellular compartment, and exit
the cell membrane from the other side of the cell (exocytosis). The P for a NP by a
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transcellular transport can calculated as

Here the diffusion permeability Pd describes how fast a NP diffuses across the
intracellular compartment, which can be obtained by,
eff

here Deff is the effective diffusion coefficient of the NP in the cell cytoplasm, which
can be estimated using the Stoke-Einstein equation,
μ
where KBT, where KB is the Boltzmann constant and T is the absolute temperature,
is the viscosity of the cytoplasm, R is the radius of the NP. Pen and Pex are the NP
permeability through the endocytosis and the exocytosis, which were assumed to be
the same.

where

is the time it takes for the cell membrane to completely engulf the NP of

diameter 2R into the cell interior.

3.2.6 Model Prediction
Effect of salt concentrations on eletrostatic surface tension of the cell
membrane
As shown above in Eq. 5 that one factor affects the cell membrane deformation is
the effective surface tension of the cell membrane, of which the electrostatic surface
tension γ

contributes significantly. γ

Debye-Huckel length.

π σ κ

. Here 1/

, here C is the salt concentration.
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= is the

Figure 3.2.6 shows the Debye-Huckel length vs. salt concentration C, which
changes from 120mM to 160mM in the plasma or the in the experimental solution
used in the in vitro BBB model . We can see from Figure 3.2.6 that when the
concentration increases from 120mM to 160mM,the Debye-Huckel length only
changes about 10%. In this way, the contribution from the salt concentration to the
electrostatic surface tension is negligible.

DH Length (nm)

1.0000
0.8000
0.6000
0.4000
0.2000
0.0000
100

120

140

160

180

200

Concentration (mM)
Figure 3.2.6 Debye-Huckel length vs. salt concentration of the solution.
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Effect of Charge Density of the Surface Glycocalyx on Eletrostatic
Surface Tension of the Cell Membrane
Since electrostatic surface tension of the cell membrane γ
also changes with the charge density of the surface glycocalyx σ,
vs. σ in Figure 3.2.7. We see that γ

π σ κ
we plotted γ

increases greatly when σ increases from 0.1

to 5 (number of electron/nm2), which is within the physiological range of the charge
density of the endothelial surface glycocalyx in vivo and in vitro (Yuan et al., 2010,
2010). Interestingly, this electrostatic surface tension of the cell membrane would
help bend the cell membrane inward and this makes the endocytosis of a neutral NP
possible. In Figure 3.2.7, we also plotted the effect of the salt concentration. As
discussed above, its contribution to the electrostatic surface tension is negligible.

Concentration=120mM

electrostatic surface tension (KBT/nm2)

Concentration=140mM
Concentration=160mM
10

1
0

0.1

0.5

1

1.5

2

charge density on SGL (number/nm2)

Figure 3.2.7 Electrostatic surface tension as a function of charge density of the
surface glycocalyx layer.
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Figure 3.2.8 Model predictions for the time changing penetrating depth into the
cell interior for neutral NPs with the diameter 20nm, 50nm and 100nm.

Fig 3.2.8 shows the model predictions for the time changing penetrating depth into the
cell interior for neutral NPs with the diameter 20nm, 50nm and 100nm. The t*, the time for

the complete wrapping of the NP, is defined as the time when the penetrating depth h
= 2R. 2R is the diameter of the NP. The charge density of the cell membrane used in
the plot was 0.5/nm2. If increasing the charge density, we found an increase in the
penetrating depth at the same time for all sized NP from 20-100 nm. It seems that as
long as there is enough charge at the cell membrane, there is a chance for a neutral NP
across the cell membrane. In addition to the charge density, the time for the
penetration is dependent on the NP size.
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Comparison of Model Prediction with Measured Permeability of bEnd3
Monolayer to Neutral and Charged NPs
Measured Permeability
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Figure 3.2.9 Model predictions for the permeability to neutral NPs as a function of
diameter from 20nm to 100nm. The charge density of the SGL at the cell monolayer is 0,
0.1, 0.5, 1/nm2.

Figure 3.2.9 shows the comparison of the model predictions and measured
permeability of the bEnd3 monolayer to the neutral NPs with diameter from 20nm to
100nm. One observation from Figure 3.2.9 is that the surface charge of the bEnd3
monolayer is crucial in neutral NP transport across the monolayer. When the charge is
zero, no NPs larger than the width of the paracellular cleft can cross the monolayer.
However, as long as the surface charge is large enough, there is always a chance for a
neutral NP in this size range passing across the monolayer. The larger the surface
charge density, the larger the NP permeability. Another observation is that the
permeability of the monolayer is almost independent of the size of the NP in this
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range although there is a slight increase when NP diameter is from 20nm to 100nm.
Comparing the model predictions with the measured permeability, we can see that for
the best fit to the measured P to neutral NPs, the charge density of the SGL would be
~0.5/ nm2. This represents a 50 nm thick SGL with volume charge density ~20mEq/L.

Permeability (10-7 cm/s )

60

Charge density = 0.5/nm2

Yuan et al 2010
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z=1300
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0
0

20
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60

80

100

120

Diameter (nm)
Figure 3.2.10 Model predictions for the permeability to the charged NPs as a
function of diameter from 20nm to 100nm. The charge density of the SGL of the
bEnd3 monolayer is 0.5/nm2.

Figure 3.2.10 shows the comparison of the model predictions and measured
permeability of the bEnd3 monolayer to the positively charged NPs with diameter
from 20nm to 100nm. Lines are model predictions when the charge number of the NP
= 1000, 3000 and 5000. The symbols are measured permeability data for three sized
NPs with different charge numbers 1300, 3390 and 4477. Figure 3.2.10 demonstrates
that our model predictions are in good agreement with the measured data. We can also
see from Figure 3.2.10 that the charge carried by the NP contributes significantly to its
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transcellular permeability in addition to the charge carried by the cell monolayer. Here
we fixed the cell surface charge at 0.5/nm2, which is in consistent with that for neutral
NP permeability (Figure 3.2.9). The same as for the neutral NP, when the cell surface
charge is zero, no charged NP can cross the monolayer no matter how much charge it
carries.

Discussion
In order to understand transcellular mechanisms of NPs across the BBB, we
developed a trans-cell membrane model based on a theory for the mechanical and
electrostatic energy of a charged membrane interacting with a oppositely charged
sphere in a salt solution. We simplified the transcellular transport of a NP into an
endocysis process, diffusion across the cytoplasm and an exocytosis process. We also
assumed that it takes the same amount of time for a NP during the endocysis and
exocytosis. Combining model predictions with the measured permeability of an in
vitro BBB to neutral and charged NPs, we found that the negative charge carried by
the SGL of the in vitro BBB is crucial to the transcellular transport of both neutral and
charged NPs with diameter ranging from 20nm to 100nm. Additionally, the opposite
charge carried by the NP can further increase its transcelluar permeability
significantly. For the NPs studied, the charge carried by the NP can increase its
permeability to 100-fold that of the neutral NP with the same size. In contrast, the size
effect of the NP on its trans-bEnd3 monolayer permeability is negligible for the NPs
with diameter 20-100 nm. The ion concentration of the surrounding salt solution also
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contributes little to the transcellular transport of the NPs.
In conclusion, our results suggest that we can control the surface charge of the
cell membrane, e.g. use orosomucoid to increase the negative charge of the SGL
(Yuan et al., 2010a, 2010b), to control the transcellular transport of NPs. We can also
decorate the NPs with positive charges to enhace its transport. Since a larger NP has
the same transcellular permeability as a smaller one in our size range, and a larger NP
can circulate longer in the body, we can choose the larger NP to load more therapeutic
agents to increase drug delivery efficiency to the brain.
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Future Studies
In the future studies, we will explore the transcellular transport of a variety of
NPs with different sizes, charges, shapes, and rigidities across a variety of cell barriers.
Guided by our newly developed transcellular transport model, we will perform more
experiments to find the optimal size and charge for the NP across specific cell barrier
in addition to the in vitro BBB. We also want to expand this model to investigate the
trans-vascular barrier transport of cells such as tumor cells, white blood cells and stem
cells.
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